UNH|Analyst Targets
UNH|Company Info
UNH|Insider Trading
UNH|Fundamentals
UNH|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $4.19 | $4.69 | +12.0% |
| Q2'26 | $3.74 | $6.38 | +70.4% |
| Q1'26 | $6.60 | $7.23 | +9.5% |
| Q4'25 | $2.12 | $2.11 | -0.6% |
| Q3'25 | $2.81 | $2.92 | +4.0% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $112.5B | $112.7B | +0.2% |
| Q2'26 | $111.9B | $112.0B | +0.1% |
| Q1'26 | $109.7B | $111.7B | +1.9% |
| Q4'25 | $115.0B | $113.2B | -1.5% |
| Q3'25 | - | $113.2B | - |
UNH|Monthly Returns
Market Data
UNH Stock Snapshot
- Market cap
- 337.65B
- P/E ratio
- 23.9
- Day range
- $377.62 – $395.50
- News sentiment
- 65/100 · Bullish
- Analyst target
- $480.60 (+22.1%)
- Consensus
- Buy · 36 analysts
The setup on UnitedHealth Group Incorporated is patient: consolidation, not accumulation or distribution. Positioning shifts among large allocators, not retail flow, set the tone for a name this size.
Reverse DCF
What growth is priced into UNH?
At today's price, UnitedHealth Group Incorporated needs to grow free cash flow about 8.6% a year for the next 10 years to justify its valuation at a 7.85% cost of capital. Over its actual history it has compounded free cash flow at 11.3% a year, so the market is asking for 2.7 percentage points below its own delivered rate. On that basis UNH looks priced roughly in line with its own growth record.
- Implied FCF growth
- 8.6%
- Historical FCF CAGR
- 11.3%
- Growth gap
- -2.7 pts
- Verdict
- FAIR
- Discount rate (WACC)
- 7.85%
- Beta
- 0.68
Behaviour On Record
What UNH's own history says about today's numbers
- Realized volatility (21d)
- 17.3% 26th pct
- Below its peak
- -39.5%
- vs 200-day average
- +6.0%
- Up days (1y)
- 47%
UnitedHealth Group Incorporated is currently running 17.3% annualised volatility over the last 21 sessions. Measured against UNH's own 13 years of daily returns rather than a market-wide average, that is the 26th percentile — on the quiet side for this stock, against a typical reading of 22.1%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
UNH is trading -39.5% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -16.0%, and the deepest was -60.6% in 2025. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.
Price sits +6.0% from its 200-day moving average. Against every other day in its history, that gap ranks at the 41st percentile — close to the gap it normally carries. Over the past year UNH closed higher on 47% of sessions, and it is currently 1 session into a rising streak.
On October specifically: over 14 years of records, UNH finished the month higher 9 of 14 times, with a median return of +2.8% and an average of +3.7%. Its strongest month historically has been November at +5.1% on average, its weakest February at -1.2%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: UNH has opened more than 2% away from the prior close in 41 of 3,268 sessions (1.3% of the time), with the largest gaps running +9.3% and -6.4%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 4 dated reports on file, UNH moved an average of 1.4% in the session after earnings, closing higher 4 of those 4 times, with a median move of +1.3% and a largest of +3.2%.
All figures computed from 3,269 daily closes between 2013-10-15 and 2026-10-14, split-adjusted, recomputed daily. Percentiles are against UNH's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of UNH's sector?
UnitedHealth Group Incorporated sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading).
- Sector rank
- #2 of 12
- Sector state
- Leading
- Sector rotation score
- 91
Analyst Rating Changes
Are analysts turning bullish or bearish on UNH?
TD Cowen most recently reiterated its rating on UnitedHealth Group Incorporated to Hold on Oct 9, 2026 with a price target of $402 (from $430). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- TD Cowen — Hold
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
Earnings Release, Scored
What did UnitedHealth Group Incorporated's latest earnings release say?
Most important lines
- 1
1 UnitedHealth Group Reports Third Quarter 2026 Results • Third Quarter 2026 Revenues of $112.7 Billion; Earnings from Operations of $6.6 Billion • Earnings of $4.56 Per Share and Adjusted Earnings of $4.69 Per Share • Cash Flows from Operations Were $5.1 Billion, or 1.2x Net Income • Updated Full Year 2026 Earnings Outlook to At Least $19.50 Per Share; Adjusted Earnings of At Least $20.50 Per Share To view this information in a different format, including graphics, published on our website, click here: https://www.unitedhealthgroup.com/content/dam/UHG/PDF/investors/2026/unh-reports-third-quarter-2026-results.pdf (October 13, 2026) UnitedHealth Group (NYSE: UNH) today reported third quarter 2026 results and raised guidance for full year 2026.
Guidance raised - 2
Optum Rx • Optum Rx continues to advance transparent pharmacy pricing while broadening the clinically integrated pharmacy services that patients depend on. • Optum Rx’s third quarter 2026 revenues were $39.9 billion compared to $39.7 billion in the third quarter 2025. • Earnings from operations for the third quarter 2026 were $1.7 billion compared to $1.5 billion in the third quarter 2025, reflecting continued adoption of biosimilars and operational improvements.
New this quarter - 3
Quarterly Financial Performance Three Months Ended September 30, 2026 September 30, 2025 June 30, 2026 Revenues $66.9 billion $69.2 billion $65.7 billion Earnings from Operations $3.7 billion $2.5 billion $4.0 billion Operating Margin 5.6% 3.6% 6.2% Optum Health • Optum Health continues to progress in operational enhancements that expand patient access to integrated, quality care resources while modernizing the care experience to allow for greater patient satisfaction and a more engaged clinician experience. • Optum Health’s third quarter 2026 revenues of $22.9 billion decreased 10% year-over-year as a result of fewer value-based care patients served in markets where Optum lacked sufficient value-based care presence to sustain its clinicians. • Third quarter 2026 earnings from operations were $735 million and operating margin was 3.2%, compared to $41 million and 0.2% in the third quarter 2025.
New this quarterNegative tone
Peers & ETF holders
UNH peers & ETF holders
Healthcare PlansMarket cap · today
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | ▲ Buy | 76,863,061 | 8.63% | $31.95B | 2026-08-07 |
| Vanguard Group Inc | ▲ Buy | 91,600,260 | 10.28% | $30.24B | 2026-01-29 |
| Capital World Investors | ▲ Buy | 29,887,932 | 3.35% | $12.42B | 2026-08-12 |
| FMR LLC (Fidelity) | ▲ Buy | 27,992,995 | 3.14% | $11.63B | 2026-08-13 |
| Geode Capital Management, LLC | ▼ Sell | 21,751,937 | 2.44% | $9.01B | 2026-08-12 |
| JPMorgan Chase & Co | ▲ Buy | 20,246,047 | 2.27% | $8.50B | 2026-08-12 |
| Morgan Stanley | ▼ Sell | 14,795,456 | 1.66% | $6.15B | 2026-08-13 |
| Norges Bank | ▼ Sell | 12,736,973 | 1.43% | $5.29B | 2026-08-12 |
| Wellington Management Group LLP | ▲ Buy | 10,675,175 | 1.20% | $4.44B | 2026-08-14 |
| Capital Research Global Investors | ▼ Sell | 10,534,177 | 1.18% | $4.38B | 2026-08-12 |
| Bank of America Corp | ▼ Sell | 9,735,874 | 1.09% | $4.05B | 2026-08-14 |
| Fisher Asset Management, LLC | ▲ Buy | 9,082,269 | 1.02% | $3.77B | 2026-08-04 |
| Northern Trust Corp | ▼ Sell | 8,761,055 | 0.98% | $3.64B | 2026-08-13 |
| Goldman Sachs Group Inc | ▼ Sell | 6,974,132 | 0.78% | $2.90B | 2026-08-14 |
| Invesco Ltd. | ▲ Buy | 6,858,984 | 0.77% | $2.85B | 2026-08-14 |
| AllianceBernstein L.P. | ▲ Buy | 7,669,420 | 0.86% | $2.08B | 2026-08-14 |
| Wells Fargo & Company | ▲ Buy | 3,618,579 | 0.41% | $1.50B | 2026-08-14 |
| Janus Henderson Group plc | ▲ Buy | 3,691,607 | 0.41% | $991.45M | 2026-05-18 |
| Susquehanna International Group, LLP | ▼ Sell | 1,883,767 | 0.21% | $782.95M | 2026-08-14 |
| Marshall Wace, LLP | ▲ Buy | 1,833,046 | 0.21% | $761.87M | 2026-08-13 |
| AQR Capital Management LLC | ▲ Buy | 1,757,550 | 0.20% | $729.08M | 2026-08-14 |
| Millennium Management LLC | ▲ Buy | 1,617,653 | 0.18% | $672.35M | 2026-08-14 |
| Davis Selected Advisers | ▲ Buy | 1,274,650 | 0.14% | $529.84M | 2026-08-11 |
| Farallon Capital Management LLC | ▼ Sell | 1,270,532 | 0.14% | $528.07M | 2026-08-14 |
| Citigroup Inc | ▼ Sell | 1,173,015 | 0.13% | $487.54M | 2026-08-03 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Maria Elvira Salazar | House | FL27 | ▼ Sell | $1K - $15K | 2026-09-24 | 2026-10-07 |
| Kevin Hern | House | OK01 | ▼ Sell | $15K - $50K | 2026-09-10 | 2026-09-25 |
| Richard Dean Dr McCormick | House | GA06 | ▼ Sell | $1K - $15K | 2026-07-30 | 2026-08-14 |
| Dan Newhouse | House | WA04 | ▼ Sell | $1K - $15K | 2026-07-10 | 2026-07-17 |
| Richard Dean Dr McCormick | House | GA06 | ▼ Sell | $1K - $15K | 2026-06-12 | 2026-07-09 |
| Maria Elvira Salazar | House | FL27 | ▼ Sell | $1K - $15K | 2026-06-04 | 2026-07-07 |
| John Boozman | Senate | AR | ▲ Buy | $1K - $15K | 2026-06-04 | 2026-07-13 |
| Maria Elvira Salazar | House | FL27 | ▲ Buy | $1K - $15K | 2026-04-22 | 2026-05-08 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2026-04-14 | 2026-05-08 |
| Alan Armstrong | Senate | OK | ▲ Buy | $15K - $50K | 2026-03-27 | 2026-07-21 |
| Richard Dean Dr McCormick | House | GA06 | ▲ Buy | $1K - $15K | 2026-03-19 | 2026-04-07 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2026-03-13 | 2026-04-07 |
| Gilbert Cisneros | House | CA31 | ▼ Sell | $15K - $50K | 2026-02-10 | 2026-03-09 |
| Josh Gottheimer | House | NJ05 | ▲ Buy | $1K - $15K | 2026-02-05 | 2026-03-16 |
| Kevin Hern | House | OK01 | ▼ Sell | $250K - $500K | 2025-12-23 | 2026-01-22 |
| Julie Johnson | House | TX32 | ▼ Sell | $1K - $15K | 2025-12-18 | 2026-01-15 |
| Julie Johnson | House | TX32 | ▼ Sell | $1K - $15K | 2025-11-13 | 2025-12-11 |
| Gilbert Cisneros | House | CA31 | ▼ Sell | $1K - $15K | 2025-11-12 | 2025-12-15 |
| Richard Dean Dr McCormick | House | GA06 | ▲ Buy | $1K - $15K | 2025-11-05 | 2025-12-09 |
| Lisa McClain | House | MI09 | ▼ Sell | $1K - $15K | 2025-10-31 | 2025-11-21 |
| Lisa McClain | House | MI09 | ▼ Sell | $1K - $15K | 2025-10-30 | 2025-11-21 |
| Lisa McClain | House | MI09 | ▲ Buy | $1K - $15K | 2025-10-30 | 2025-11-21 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2025-10-09 | 2025-11-18 |
| Valerie Hoyle | House | OR04 | ▼ Sell | $1K - $15K | 2025-09-23 | 2025-10-10 |
| Richard Dean Dr McCormick | House | GA06 | ▼ Sell | $1K - $15K | 2025-09-18 | 2025-10-09 |